The Ever-Expanding Multiple Sclerosis Therapeutics

• Ahmed Obeidat, MD, PhD
  Assistant Professor, Department of Neurology, Neuroimmunology and Multiple Sclerosis; Director, Neuroimmunology and MS Fellowship Program, The Medical College of Wisconsin
• Suma Shah, MD
  Director, MS & Neuroimmunology Fellowship, Duke University School of Medicine
• S. Mitchell Freedman, MD FAAN
  Adjunct Professor of Neurology, University of North Carolina-Chapel Hill

Key Learning Objectives

• Virtual patient visits during COVID-19 when treating MS
• Changing barriers to treating MS
• Evolution of monitoring safety and efficacy of therapy
• The future of treating MS